Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04641650
What this trial is testing

Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsis

Who this might be right for
Kidney FailureDiabetes
Centre Hospitalier Saint Joseph Saint Luc de Lyon 29
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Large-scale testing (Phase 3)Study completedNCT01785849
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 508
Testing effectiveness (Phase 2)Study completedNCT01146574
What this trial is testing

A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.

Who this might be right for
Anemia
Celgene 50
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Early research (Phase 1)Study completedNCT03442725
What this trial is testing

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Ipsen 16
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Large-scale testing (Phase 3)Study completedNCT00112008
What this trial is testing

Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis

Who this might be right for
Chronic Kidney DiseaseKidney Disease
Amgen 100
Large-scale testing (Phase 3)Study completedNCT02282813
What this trial is testing

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondaryVitamin D Deficiency
OPKO Health, Inc. 298
Testing effectiveness (Phase 2)Study completedNCT01660295
What this trial is testing

Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT04446507
What this trial is testing

A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects with Severe Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Zydus Therapeutics Inc. 32
Large-scale testing (Phase 3)WithdrawnNCT00869856
What this trial is testing

Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

Who this might be right for
AnemiaChronic Renal Insufficiency
Sandoz
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02019719
What this trial is testing

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anaemia
GlaxoSmithKline 97
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Early research (Phase 1)Study completedNCT03893799
What this trial is testing

RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease

Who this might be right for
Healthy VolunteersChronic Kidney Disease
Renibus Therapeutics, Inc. 54
Early research (Phase 1)Study completedNCT02402452
What this trial is testing

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

Who this might be right for
HCV Infection
Gilead Sciences 20
Early research (Phase 1)UnknownNCT02356419
What this trial is testing

RESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Who this might be right for
Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD. 40
Early research (Phase 1)Study completedNCT02674581
What this trial is testing

The Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)

Who this might be right for
HIV Infections
ViiV Healthcare 30
Next Page